[HTML][HTML] Fibrosis regression following hepatitis C antiviral therapy

A Elsharkawy, R Samir, M El-Kassas - World Journal of Hepatology, 2022 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) infection is one of the most common causes of liver pathology. It is a
major etiological factor of continuous liver injury by triggering an uncontrolled inflammatory …

Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients

E Abdelsameea, A Alsebaey… - Expert Review of Anti …, 2021 - Taylor & Francis
Objectives Extent of post-treatment fibrosis change in patients with different stages of fibrosis
not fully known. We aimed to study changes in liver fibrosis in chronic hepatitis C patients …

Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV–VII

S Han, GH Sung, S Lee, KJ Han, HJ Han - Medicine, 2022 - journals.lww.com
Although cadmium (Cd) is correlated with elevated levels of hepatic amino transferases, its
influence on the degree of liver steatosis and fibrosis are unknown yet. We aimed to …

Non‐invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)‐associated liver disease and …

V Knop, D Hoppe, J Vermehren… - Journal of viral …, 2021 - Wiley Online Library
Long‐term effects on cirrhosis and portal hypertension of direct antiviral agent (DAA)‐based
eradication of hepatitis C virus (HCV) are still under debate. We analysed dynamics of liver …

Changes in liver stiffness and noninvasive fibrosis scores in Egyptian adolescents successfully treated with ledipasvir-sofosbuvir for chronic hepatitis C virus infection

DM Fahmy, M Shokeir, SM El Zeiny, MM Jonas… - The Journal of …, 2021 - Elsevier
Objective To assess changes in noninvasive liver fibrosis measurements after chronic
hepatitis C eradication by direct-acting antivirals in Egyptian adolescents. Study design Liver …

Pro-neurotensin as a potential novel diagnostic biomarker for detection of nonalcoholic fatty liver disease

AA Mohamed, DM Abo-Elmatty, O Ezzat… - … syndrome and obesity …, 2022 - Taylor & Francis
Background and Aims Currently, liver biopsy is the gold standard method for diagnosis of
non-alcoholic fatty liver severity. It is critical to develop non-invasive diagnostic method to …

Seroprevalence of hepatitis C virus infection in children: A systematic review and meta‐analysis

M Abdel‐Gawad, S Abd‐elsalam… - Liver …, 2022 - Wiley Online Library
Abstract Background and Aims Estimates of paediatric hepatitis C virus (HCV)
seroprevalence are needed to aid treatment scaling‐up, screening and detection approach …

Impact of sustained virological response for gastroesophageal varices in hepatitis-C-virus-related liver cirrhosis

Y Yuri, H Nishikawa, H Enomoto, K Yoh… - Journal of Clinical …, 2019 - mdpi.com
We aimed to clarify the relationship between sustained virological response (SVR) and
gastroesophageal varices (GEVs) progression among hepatitis C virus (HCV)-related liver …

[HTML][HTML] Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected …

M Laguno, M Martínez-Rebollar, M Casanova… - Clinical Microbiology …, 2022 - Elsevier
Abstract Objective Hepatitis C virus (HCV) therapy with direct-acting antivirals (DAA)
achieves high rates of sustained virological response in people living with human …

Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients

AE Ebrahim, MAH Shehata, S Abou-saif… - Egyptian Journal of …, 2020 - Springer
Background Liver cancer (HCC) ranks as the fifth most prevalent cancer worldwide and is
ranked third as a common cause of death due to cancer. The benefit of Fibroscan in …